Evidence map›Paper›PMID 32952608›Full record

ArticleEvolutionary applications2020

Application of simultaneous selective pressures slows adaptation.

Lauren M F Merlo, Kathleen Sprouffske, Taylor C Howard, Kristin L Gardiner, Aleah F Caulin, Steven M Blum, Perry Evans, Antonio Bedalov, Paul D Sniegowski, Carlo C Maley

Abstract read
In one paragraph

Article in Evolutionary applications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Cancer in light of experimental evolution.Current biology : CB · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lauren M F MerloLankenau Institute for Medical Research Wynnewood Pennsylvania USA.
Kathleen SprouffskeDisease Area Oncology Novartis Institutes for BioMedical Research Basel Switzerland.
Taylor C HowardDepartment of Pathology and Laboratory Medicine UC Davis Health Sacramento California USA.
Kristin L GardinerSchool of Veterinary Medicine University of Pennsylvania Philadelphia Pennsylvania USA.
Aleah F CaulinPEEL Therapeutics, Inc. Salt Lake City Utah USA.
Steven M BlumDepartment of Medical Oncology Dana-Farber Cancer Institute Broad Institute at MIT and Harvard Harvard Medical School, and Massachusetts General Hospital Cancer Center Boston Massachusetts USA.
Perry EvansDepartment of Biomedical and Health Informatics Children's Hospital of Philadelphia Philadelphia Pennsylvania USA.
Antonio BedalovClinical Research Division Fred Hutchinson Cancer Research Center Seattle Washington USA.
Paul D SniegowskiDepartment of Biology University of Pennsylvania Philadelphia Pennsylvania USA.
Carlo C MaleyArizona State University School of Life Sciences Biodesign Institute Tempe Arizona USA.ORCID https://orcid.org/0000-0002-0745-7076

Funding

Training Program in Computational GenomicsT32HG000046 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI JUNHYONG KIM, Mingyao Li · 1999 to 2026
$9.5M
The Role of the Microbiome in Cancer Suppression and Susceptibility Across SpeciesU54CA217376 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MALEY, CARLO · 2018 to 2022
$8.6M
Modeling Neoplastic Progression in Barrett's Esophagus - Renewal -2R01CA140657 · NCI · WISTAR INSTITUTE · PI Carlo Maley · 2009 to 2026
$5.0M
Origin firing at repetitive sequences and genome replication - Admin SupplementR01GM117446 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BEDALOV, ANTONIO · 2016 to 2023
$4.3M
NCI NIH HHS R01 CA140657NCI NIH HHS U54 CA217376NHGRI NIH HHS T32 HG000046NIGMS NIH HHS R01 GM117446
6 · The paper itself

Abstract

Beneficial mutations that arise in an evolving asexual population may compete or interact in ways that alter the overall rate of adaptation through mechanisms such as clonal or functional interference. The application of multiple selective pressures simultaneously may allow for a greater number of adaptive mutations, increasing the opportunities for competition between selectively advantageous alterations, and thereby reducing the rate of adaptation. We evolved a strain of

Indexed as

adaptationcancer therapyclonal interferencefunctional interferenceslowing evolution

Identifiers

PMID32952608
PMCPMC7484835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.